微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -1.3% | 55.63% | -96.97% | 109/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -0.66% | 74.12% | 83.98% | 112/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -4.12% | -562.92% | -148.19% | 109/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -1.66% | -401.82% | 43.34% | 115/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -2.93% | -453.01% | -14.9% | 122/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -2.55% | -1442.11% | -386.52% | 127/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 0.89% | 27.14% | 61.82% | 91/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.55% | -44.44% | -33.73% | 103/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.83% | 245.83% | 336.84% | 91/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.19% | 5.56% | -72.86% | 102/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 0.7% | 106.23% | -29.29% | 101/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 0.99% | 114.29% | 312.5% | 104/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.24% | 106.72% | 33.33% | 110/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.18% | 112.68% | 101.6% | 106/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | -11.23% | -274.38% | -62.05% | 124/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | -6.93% | -207.78% | -94.12% | 115/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | -3.57% | -173.31% | -151.41% | 120/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | -1.42% | -155.25% | -122.05% | 108/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 6.44% | -49.45% | 0.16% | 103/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 6.43% | -23.91% | 32.03% | 85/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 4.87% | 17.63% | 89.49% | 81/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.57% | 96.18% | -79.83% | 59/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 12.74% | -4.35% | 50.77% | 77/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 8.45% | -29.99% | 104.11% | 60/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 4.14% | -32.79% | 216.03% | 79/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.31% | -47.39% | -90.17% | 52/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 13.32% | -38.9% | 10.36% | 61/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 12.07% | -23.32% | 95.94% | 24/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 6.16% | -43.59% | 147.39% | 33/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.49% | 2% | -88.58% | 26/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 21.8% | -3.67% | 38.5% | 26/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 15.74% | 2% | 44.14% | 8/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 10.92% | 2% | -51.75% | 6/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2017-12-31 | 22.63% | -2.12% | -2.12% | 23/141 | 14.51% | 迈瑞医疗 | 11% | 行业排名> |
| 2016-12-31 | 23.12% | 2% | 2% | 19/141 | 16.44% | 安旭生物 | 59.22% | 行业排名> |